Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma Thyroid Powder

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Thyroid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 18,398Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viridian Completes THRIVE-2 Enrollment For VRDN-001 In Chronic TED
    Viridian Completes THRIVE-2 Enrollment For VRDN-001 In Chronic TED

    25 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240725241981/en

    BUSINESSWIRE
    25 Jul 2024
    Share Share
    AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer
    AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer

    23 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240723305679/en

    BUSINESSWIRE
    23 Jul 2024
    Share Share
    Veracyte's Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis
    Veracyte's Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603031308/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Entera's Oral PTH Hypoparathyroidism Candidate EB612 Phase 1 Data
    Entera's Oral PTH Hypoparathyroidism Candidate EB612 Phase 1 Data

    03 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/03/2892199/0/en/Entera-Bio-Reports-Phase-1-Clinical-Data-of-First-in-Class-Oral-PTH-1-34-Peptide-Candidate-EB612-for-Patients-with-Hypoparathyroidism-at-ENDO-2024.html

    GLOBENEWSWIRE
    03 Jun 2024
    Share Share
    Izeen Pharma Inc Receives FDA Warning Letter
    Izeen Pharma Inc Receives FDA Warning Letter

    03 Jul 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/izeen-pharma-inc-receives-fda-warning-letter-1562148790.pdf

    FDA
    03 Jul 2019
    Share Share
    FDA Sends Warning Letters to Aurobindo, API Repackers
    FDA Sends Warning Letters to Aurobindo, API Repackers

    03 Jul 2019

    // Michael Mezher RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/7/fda-sends-warning-letters-to-aurobindo-api-repack?feed=Regulatory-Focus

    Michael Mezher RAPS
    03 Jul 2019
    Share Share